ArticleInfection and drug resistance2025

Palivizumab for Severe Respiratory Syncytial Virus Infection in Immunocompetent Adults: A Case Series.

Jun-Yu Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.